Publication (당뇨병, 대사증후군, 비만, 동맥경화 관련 논문 250여편)
[ 2015년 ]
Hong ES, Khang AR, Roh E, Ku EJ, Kim YA, Kim KM, Moon JH, Choi SH, Park KS, Kim KW, Jang HC, Lim S (corresponding). Counterintuitive relationship between visceral fat and all-cause mortality in an elderly Asian population. Obesity 2015 Jan;23(1):220-7. (SCI IF= 3.873)
Moon JH*, Lim S* (cofirst), Han JW, Kim KM, Choi SH, Park KS, Kim KW, Jang HC. Carotid Intima-Media Thickness Is Associated With the Progression of Cognitive Impairment in Older Adults. Stroke. 2015 Apr;46(4):1024-30 (SCI IF= 6.032)
Choi SH*, Lim S*(cofirst), Hong ES, Seo JA, Park CY, Noh JH, Mok JO, Lee KY, Park JS, Kim DJ, Lee CB, Kim SR, Jang HC. PROPIT: A PROspective comparative clinical study evaluating the efficacy and safety of PITavastatin in patients with metabolic syndrome. Clin Endocrinol (Oxf). 2015 May;82(5):670-7. (SCI IF= 3.327)
Ku EJ, Jung KY, Kim YJ, Kim KM, Moon JH, Choi SH, Cho YM, Park KS, Jang HC, Lim S (corresponding), Ahrén B. Four-year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC study. PLoS One 2015 Jun 12;10(6):e0129477 (SCI IF= 2.806)
Kim KM, Lee KS, Lee GY, Jin H, Durrance ES, Park HS, Choi SH, Park KS, Kim YB, Jang HC, Lim S (corresponding). Anti-diabetic efficacy of KICG1338, a novel glycogen synthase kinase-3β inhibitor, and its molecular characterization in animal models of type 2 diabetes and insulin resistance. Mol Cell Endocrinol. 2015 Jul 5;409:1-10 (SCI IF= 3.754)
Cho NH, Kim KM, Choi HS, Park KS, Jang HC, Kim SS, Sattar N, Lim S (corresponding). High Blood Pressure and Its Association with Incident Diabetes Mellitus over 10 Years in the Korean Genome and Epidemiology Study (KoGES), Diabetes Care 2015 Jul;38(7):1333-8. (SCI IF= 11.857)
Hong AR, Lee J, Ku EJ, Hwangbo Y, Kim KM, Moon JH, Choi SH, Jang HC, Lim S (corresponding). Comparison of vildagliptin as an add-on therapy and sulfonylurea dose-increasing therapy in patients with inadequately controlled type 2 diabetes using metformin and sulfonylurea (VISUAL study): A randomized trial. Diabetes Res Clin Pract 2015 Jul;109(1):141-8. (SCI IF= 3.639)
Moon JH*, Lim S*(cofirst), Han JW, Kim KM, Choi SH, Kim KW, Jang HC. Serum 25-hydroxyvitamin D level and the risk of mild cognitive impairment and dementia: the Korean Longitudinal Study on Health and Aging. Clinical Endocrinology 2015 Jul;83(1):36-42. (SCI IF= 3.327)
Lim S (first), Oh TJ, Koh KK. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. Int J Cardiol. 2015 Dec 15;201:408-14. (SCI IF= 6.189)
Lim S (first), Lee KS, Lee J, Park HS, Kim KM, Moon JH, Choi SH, Park KS, Kim YB, Jang HC. Effect of a new PPAR-gamma agonist, lobeglitazone, on neointimal formation after balloon injury in rats and the development of atherosclerosis. Atherosclerosis 2015 Sep 4;243(1):107-119 (SCI IF= 4.239)
Hong AR, Lim S (corresponding). Clinical Characteristics of Metabolic Syndrome in Korea and Its Comparison with Other Asian Countries. J Diabetes Investig. 2015 Sep 6;5:508-515 (SCI IF= 3.039)
Kim KM, Park KS, Lee HJ, Lee YH, Bae JS, Lee YJ, Choi SH, Jang HC, Lim S (corresponding). Efficacy of a New Medical Information system, Ubiquitous Healthcare Service with Voice Inception Technique in Elderly Diabetic Patients. Sci Rep. 2015 Dec 11;5:18214. (SCI IF= 4.259)
Cho NH, Oh TJ, Kim KM, Choi SH, Lee JH, Park KS, Jang HC, Kim JY, Lee HK, Lim (corresponding)S. Neck Circumference and Incidence of Diabetes Mellitus over 10 Years in the Korean Genome and Epidemiology Study (KoGES). Sci Rep. 2015Dec 18;5:18565 (SCI IF= 4.259)
Lee DH, Park KS, Ahn S, Ku EJ, Jung KY, Kim YJ, Kim KM, Moon JH, Choi SH, Park KS, Jang HC, Lim S (corresponding). Comparison of Abdominal Visceral Adipose Tissue Area Measured by Computed Tomography with That Estimated by Bioelectrical Impedance Analysis method in Korean subjects. Nutrients. 2015 Dec 16;7(12):10513-24. (SCI IF= 3.550)
Kim KM, Lim S*(cofirst), Choi KM, Kim JH, Yu SH, Kim TN, Song W, Lim JY, Won CW, Yoo HJ, Jang HC. Sarcopenia Study Group of Korean Geriatrics Society. Sarcopenia in Korea. J Korean Geriatr Soc 2015;19(1):1-8
[ 2016년 ]
Jung KY, Kim KM, Ku EJ, Kim YJ, Lee DH, Choi SH, Jang HC, Shin CS, Park KS, Lim S (corresponding). Age- and Sex-specific Association of Circulating Osteocalcin with Dynamic Measures of Glucose Homeostasis. Osteoporos Int. 2016 Mar;27(3):1021-9. (SCI IF= 3.591)
Park KS, Lee DH, Lee JE, Jung KY, Kim YJ, Kim KM, Kwak SH, Choi SH, Jang HC, Lim S (corresponding). Comparison between two methods of bioelectrical impedance analyses for accuracy in measuring abdominal visceral fat area. J Diabetes Complications. 2016 Mar;30(2):343-9. (SCI IF= 2.734)
Lim S (first), Kang SM, Kim KM, Moon JH, Choi SH, Hwang H, Jung HS, Park KS, Ryu JO, Jang HC. Multifactorial Intervention in Diabetes Care Using Real-Time Monitoring and Tailored Feedback in Type 2 Diabetes. Acta Diabetologica 2016 Apr;53(2):189-98. (SCI IF= 3.340)
Kim KM, Jang HC, Lim S (corresponding). Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia. Korean J Intern Med. 2016 Jul;31(4):643-50. (SCI IF= 1.729)
Kim LK, Yoon JW, Lee DH, Kim KM, Choi SH, Park KS, Jang HC, Kim MK, Park HE, Choi SY, Lim S (corresponding). Impact of metabolic syndrome on the progression of coronary calcium and of coronary artery disease assessed by repeated cardiac computed tomography scans. Cardiovasc Diabetol. 2016 Jun 28;15(1):92 (SCI IF= 4.752)
Lee JE, Min SH, Lee DH, Oh TJ, Kim KM, Moon JH, Choi SH, Park KS, Jang HC, Lim S (corresponding). Comprehensive assessment of lipoprotein subfraction profiles according to glucose metabolism status, and association with insulin resistance in subjects with early-stage impaired glucose metabolism. Int J Cardiol. 2016 Dec 15;225:327-331. (SCI IF= 6.189)
[ 2017년 ]
Lim S (first), Han KA, Yu JM, Chamnan P, Kim ES, Yoon KH, Kwon S, Moon MK, Lee KW, Kim DJ, Kim M, Wongtanate M, Kim EY, Kim SH, Lee MK; INICOM Study Group. Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: a double-blind randomized controlled trial (INICOM study). Diabetes Obes Metab. 2017 Jan;19(1):87-97. (SCI IF= 6.715)
Han JH, Oh TJ, Lee G, Maeng HJ, Lee DH, Kim KM, Choi SH, Jang HC, Lee HS, Park KS, Kim YB, Lim S (corresponding). The beneficial effects of empagliflozin, a sodium/glucose cotransporter 2 inhibitor, on atherosclerosis in ApoE–/– mice fed a Western diet. Diabetologia. 2017 Feb;60(2):364-376 (SCI IF= 6.080)
Lim S (first), Lee GY, Park HS, Lee DH, Oh TJ, Kim KM, Kim YB, Jun HS, Jang HC, Park KS. Attenuation of carotid neointimal formation after direct delivery of a recombinant adenovirus expressing glucagon-like peptide-1 in diabetic rats. Cardiovasc Res. 2017 Feb;113(2):183-194. (SCI IF= 5.878)
Lee DH, Chun EJ, Hur JH, Min SH, Lee JE, Oh TJ, Kim KM, Jang HC, Han SJ, Kang DK, Kim HJ, Lim S (corresponding). Effect of sarpogrelate, a selective 5-HT2A receptor antagonist, on characteristics of coronary artery disease in patients with type 2 diabetes. Atherosclerosis. 2017 Feb;257:47-54. (SCI IF= 4.239)
Oh TJ, Lim S (cofirst author), Kim KM, Moon JH, Choi SH, Cho YM, Park KS, Jang H, Cho NH. One-hour postload plasma glucose concentration in people with normal glucose homeostasis predicts future diabetes mellitus: a 12-year community-based cohort study. Clin Endocrinol (Oxf). 2017 Apr;86(4):513-519. (SCI IF= 3.327)
Ahn CH, Min SH, Lee DH, Oh TJ, Kim KM, Moon JH, Choi SH, Park KS, Jang HC, Ha J, Sherman A, Lim S (corresponding). Hemoglobin Glycation Index Is Associated with Cardiovascular Diseases in People with Impaired Glucose Metabolism. J Clin Endocrinol Metab. 2017 Aug 1;102(8):2905-2913. (SCI IF= 5.455)
Min SH, Kong SH, Lee JE, Lee DH, Oh TJ, Kim KM, Park KS, Jang HC, Lim S (corresponding). Association of angiotensin-II levels with albuminuria in subjects with normal glucose metabolism, prediabetes, and type 2 diabetes mellitus. J Diabetes Complications. 2017 Oct;31(10):1499-1505. (SCI IF= 2.734)
Kim YJ, Hwang SD, Oh TJ, Kim KM, Jang HC, Kimm H, Kim HC, Jee SH, Lim S (corresponding). Association Between Obesity and Chronic Kidney Disease, Defined by Both Glomerular Filtration Rate and Albuminuria, in Korean Adults. Metab Syndr Relat Disord. 2017 Oct;15(8):416-422. (SCI IF= 1.932)
Tatiana Toro-Ramos, Dong-Hwa Lee, Youngin Kim, Andreas Michaelides, Tae Jung Oh, Kyoung Min Kim, Hak Chul Jang, Soo Lim (corresponding). Effectiveness of a Smartphone Application for the Management of Metabolic Syndrome Components Focusing on Weight Loss: A Preliminary Study. Metab Syndr Relat Disord. 2017 Nov;15(9):465-473 (SCI IF= 1.932)
Kim KM, Jung KY, Yun HM, Lee SY, Oh TJ, Jang HC, Lim S. Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report. Cardiovasc Diabetol. 2017 Nov 9;16(1):146. (SCI IF= 4.752)
Lim S (first), Kim KM, Kim SG, Kim DM, Woo JT, Chung CH, Ko KS, Park JH, Park Y, Kim SJ, Jang HC, Choi DS. Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes over 52 Weeks. Diabetes Metab J. 2017 Oct;41(5):377-385
Song YS, Oh TJ, Kim KM, Moon JH, Choi SH, Jang HC, Park KS, Lim S (corresponding). Application of the 2013 ACC/AHA Cholesterol Guideline to the Korean National Health and Nutrition Examination Surveys from 1998 to 2012. Diabetes Metab J. 2017 Feb;41(1):38-50.
Kim KM, Jin HJ, Lee SY, Maeng HJ, Lee GY, Oh TJ, Choi SH, Jang HC, Lim S (corresponding). Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice. Endocrinol Metab (Seoul). 2017 Sep;32(3):389-395.
Lim S (first). Journal of Obesity & Metabolic Syndrome: A New International Journal Targeting the Pathophysiology and Treatment of Obesity and Metabolic Syndrome. J Obes Metab Syndr 2017 Sep;26:81-88.
[ 2018년 ]
Min SH, Oh TJ, Baek SI, Lee DH, Kim KM, Moon JH, Choi SH, Park KS, Jang HC, Lim S (corresponding). Degree of Ketonemia and its Association with Insulin Resistance after Dapagliflozin Treatment in Type 2 Diabetes. Diabetes Metab. 2018 Feb;44(1):73-76. (SCI IF= 4.101)
Kim KM*, Lim S(cofirst)*, Oh TJ, Moon JH, Choi SH, Lim JY, Kim KW, PhD, Park KS, Jang HC. Longitudinal changes in muscle mass and strength, and bone mass in older adults: gender-specific associations between muscle and bone losses. J Gerontol A Biol Sci Med Sci. 2018 Jul 9;73(8):1062-1069.
Jung KY, Kim KM, Han SK, Yun HM, Oh TJ, Choi SH, Park KS, Jang HC, Lim S (corresponding). Effect of Rosuvastatin on Cholesterol Efflux Capacity and Endothelial Function in Type 2 Diabetes Mellitus and Dyslipidemia. Circ J. 2018 Apr 25;82(5):1387-1395.
Min SH, Kim SH, Jeong IK, Cho HC, Jeong JO, Lee JH, Kang HJ, Kim HS, Park KS, Lim S. Independent Association of Serum Aldosterone Level with Metabolic Syndrome and Insulin Resistance in Korean Adults. Korean Circ J. 2018 Mar;48(3):198-208 (SCI IF= 1.252)
Lim S, Kim KM, Nauck MA. Glucagon-like Peptide-1 Receptor Agonists and Cardiovascular Events: Class Effects versus Individual Patterns. Trends Endocrinol Metab. 2018 Apr;29(4):238-248. (SCI IF= 10.893)
Lim S, Eckel RH, Koh KK. Clinical implications of current cardiovascular outcome trials with sodium glucose cotransporter-2 (SGLT2) inhibitors. Atherosclerosis. 2018 Mar 8;272:33-40. (SCI IF= 4.239)
Lee SY, Ahn S, Kim YJ, Ji MJ, Kim KM, Choi SH, Jang HC, Lim S. Comparison between Dual-Energy X-ray Absorptiometry and Bioelectrical Impedance Analyses for Accuracy in Measuring Whole Body Muscle Mass and Appendicular Skeletal Muscle Mass. Nutrients. 2018 Jun 7;10(6).
Roh E, Kim KM, Park KS, Kim YJ, Chun EJ, Choi SH, Park KS, Jang HC, Lim S. Comparison of pancreatic volume and fat amount linked with glucose homeostasis between healthy Caucasians and Koreans. Diabetes Obes Metab. 2018 Jun 22. doi: 10.1111/dom.13447. [Epub ahead of print]
Lim S. Eating a Balanced Diet: A Healthy Life through a Balanced Diet in the Age of Longevity. J Obes Metab Syndr. 2018;27(1):39-45
https://doi.org/10.7570/jomes.2018.27.1.39
